重慶機電(02722.HK)3月25日董事會審議及批准年度業績
格隆匯 3 月 10日丨重慶機電(02722.HK)公佈,將於2021年3月25日(星期四)上午九時正假座中國‧重慶市北部新區黃山大道中段60號機電大廈16樓會議室召開董事會會議,以審議以下事項:審議及批准集團截至2020年12月31日止年度之經審核財務報表、董事會報吿及核數師報吿;審議及批准集團截至2020年12月31日止年度的經審核全年業績公吿於香港聯合交易所有限公司及公司網站上發佈;審議及批准集團2020年年報;審議公司截至2020年12月31日止年度的利潤分配方案及派發末期股息(如有);審議公司應屆股東周年大會的時間、地點及議程;及處理其他任何事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.